100-fold but not 50-fold dystrophin overexpression aggravates electrocardiographic defects in the mdx model of Duchenne muscular dystrophy

Dystrophin gene replacement holds the promise of treating Duchenne muscular dystrophy. Supraphysiological expression is a concern for all gene therapy studies. In the case of Duchenne muscular dystrophy, Chamberlain and colleagues found that 50-fold overexpression did not cause deleterious side effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Yongping, Wasala, Nalinda B, Bostick, Brian, Duan, Dongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934459/
https://www.ncbi.nlm.nih.gov/pubmed/27419194
http://dx.doi.org/10.1038/mtm.2016.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934459/
https://www.ncbi.nlm.nih.gov/pubmed/27419194
http://dx.doi.org/10.1038/mtm.2016.45

Ejemplares similares